Salona Global Medical Device (TSE:EVMT) has released an update.
Evome Medical Technologies announced approval of all matters at its annual general meeting, including an amendment to its 2023 Equity Incentive Plan. This amendment increases the maximum number of common shares available for issuance, enhancing the company’s ability to attract and retain top talent.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Paramount Global (NASDAQ:PARA) Adds an Ad-Supported Tier in Europe
- How Ford (NYSE:F) Looks to Solve Its Hydrogen Engine Problem
- The Intel (NASDAQ:INTC) “Coffee Debacle” Is Now Solved
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
